Cerebellar hematoma in severe hemophilia with inhibitor on emicizumab prophylaxis: a case report

被引:1
|
作者
Albattat, Sami [1 ]
Alabdultaif, Abbas [1 ]
Albattat, Fatimah [2 ]
Albattat, Batla [2 ]
机构
[1] Minist Hlth, Matern & Childrens Hosp Alhassa, Pediat Dept, Najran, Saudi Arabia
[2] King Faisal Univ, Alhassa, Saudi Arabia
关键词
Emicizumab; Hemophilia A; Cerebral hemorrhage; INTRACRANIAL HEMORRHAGE;
D O I
10.1186/s13256-023-03783-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundEmicizumab is a novel prophylactic medication used to treat patients with hemophilia A. It is indicated to minimize the frequency of bleeding episodes and the severity of serious bleeding in patients with hemophilia A utilizing inhibitors. However, some cases of bleeding episodes have been reported, and more data are needed regarding their management and expected outcomes.Case presentationWe report a case of a 4-year-old Saudi Arabian boy with severe hemophilia A who presented with a post-traumatic cerebral hemorrhage. The patient, with high titer inhibitors, was on emicizumab prophylaxis therapy. On hospital admission, he received tranexamic acid (10 mg intravenously, every 6 hours), and recombinant activated factor VII 120 mu g/kg every 2 hours for 2 days then every 4 hours for 4 days. On follow-up, the patient showed no signs of neurological deficit. There was no need for emergency neurosurgical intervention since the bleeding had been controlled throughout the first 2 days. There were no recorded thrombotic sequelae or neurological complications, with complete resolution within 10 days.ConclusionsThis case implies that low-dose recombinant activated factor VII might be used safely and effectively with patients with hemophilia A on emicizumab prophylaxis, to reduce the risk of cerebral hemorrhage or another episode of serious bleeding along with its long-term complications.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Cerebellar hematoma in severe hemophilia with inhibitor on emicizumab prophylaxis: a case report
    Sami Albattat
    Abbas Alabdultaif
    Fatimah Albattat
    Batla Albattat
    Journal of Medical Case Reports, 17
  • [2] Emicizumab prophylaxis in a Korean child with severe hemophilia A and high titer inhibitor: a case report
    Ahn, Ji Hyun
    Jung, Nani
    Shim, Ye Jee
    Kim, Heung Sik
    BLOOD RESEARCH, 2021, 56 (01) : 44 - 46
  • [3] Cholecystectomy in a man with hemophilia A and inhibitor on emicizumab prophylaxis: A case report
    Giacometto, Paula Cella
    Bavaresco, Marcello Tortelli
    Alvares-Teodoro, Juliana
    Camelo, Ricardo Mesquita
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 (02) : 201 - 204
  • [4] EMICIZUMAB PROPHYLAXIS IN A PATIENT WITH ACQUIRED HEMOPHILIA (TEXAS PROTOCOL): CASE REPORT
    Escobar, M.
    Aboshady, I.
    Montanez, N.
    HAEMOPHILIA, 2021, 27 : 69 - 69
  • [5] Real-world case series and summary of current literature of infants and toddlers with severe hemophilia A with inhibitor on prophylaxis with emicizumab
    Garcia, Jessica
    Zia, Ayesha
    PEDIATRIC BLOOD & CANCER, 2021, 68 (05)
  • [6] EMICIZUMAB PROPHYLAXIS IN INFANTS WITH SEVERE HEMOPHILIA A: MANAGEMENT OF 6 CASES
    Wang, Cassandra
    Kizilocak, Hande
    Young, Guy
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [7] Transplacental transfer of emicizumab: Experience with emicizumab in a pregnant female with severe hemophilia A and an inhibitor
    Kharel, Zeni
    Pruthi, Rajiv K.
    Kouides, Peter
    Reid, Robin
    HAEMOPHILIA, 2024, 30 (03) : 868 - 871
  • [8] Emicizumab Prophylaxis in Hemophilia A with Inhibitors
    Wada, Hideo
    Matsumoto, Takeshi
    Katayama, Naoyuki
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (22): : 2193 - 2194
  • [9] Emicizumab Prophylaxis in Hemophilia A with Inhibitors
    Oldenburg, Johannes
    Mahlangu, Johnny N.
    Kim, Benjamin
    Schmitt, Christophe
    Callaghan, Michael U.
    Young, Guy
    Santagostino, Elena
    Kruse-Jarres, Rebecca
    Negrier, Claude
    Kessler, Craig
    Valente, Nancy
    Asikanius, Elina
    Levy, Gallia G.
    Windyga, Jerzy
    Shima, Midori
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (09): : 809 - 818
  • [10] Prophylaxis in patients with severe hemophilia and inhibitor
    Jimenez-Yuste, V.
    Alvarez, M.
    Quintana, M.
    Rodrigo, E.
    Garcia, M.
    Hernandez-Navarro, F.
    HAEMOPHILIA, 2008, 14 : 48 - 48